GlassScriptPhysician profile
Carol Mccullough
NPI 1316940471
$1,506.02
in general payments reported to CMS, 2019-2025
29 companies · $28.09 in 2025
The $28.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $278 · 2021: $115 · 2022: $15.94 · 2023: $102 · 2024: $129 · 2025: $28.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $269.29 | 2019-2025 | |
| Hologic Sales and Service, LLC | $139.51 | 2019-2023 | Aptima |
| Boston Scientific Corporation | $85.05 | 2019 | |
| Coopersurgical, INC. | $81.41 | 2019-2024 | Summit Doppler |
| Ascend Therapeutics US, LLC | $76.24 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $76.23 | 2019-2020 | |
| Pfizer INC. | $72.85 | 2019-2021 | |
| Daiichi Sankyo INC. | $68.26 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.58 | 2019-2020 | |
| Astellas Pharma US INC | $63.89 | 2019-2023 | Veozah |
| Roche Diagnostics Corporation | $58.73 | 2019-2020 | |
| Aspira Women'S Health INC | $52.42 | 2021 | |
| Duchesnay USA Incorporated | $44.68 | 2019 | |
| Allergan, INC. | $35.76 | 2019-2020 | |
| Csl Behring | $34.74 | 2023 | Haegarda |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $34.49 | 2019-2020 | |
| Organon LLC | $34.23 | 2022-2024 | |
| Osiris Therapeutics INC. | $29.42 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.86 | 2019 | |
| Exeltis, USA INC. | $25.30 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $18.97 | 2021 | |
| Ethicon US, LLC | $16.55 | 2019 | |
| Pharmacosmos Therapeutics INC. | $15.85 | 2021 | |
| Lupin INC. | $14.95 | 2019 | |
| Minerva Surgical, INC | $14.33 | 2024 | |
| Mylan Pharmaceuticals INC. | $13.20 | 2020 | |
| Myovant Sciences INC. | $12.70 | 2021 | |
| Olympus America INC. | $11.47 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.